Abstract
Background and study aims
Small bowel capsule endoscopy (SBCE) is crucial in diagnosing small bowel diseases,
yet incomplete examinations often result from prolonged gastric transit time. This
study aimed to assess the efficacy of orally administered peppermint oil solution
as a prokinetic agent to improve SBCE completion rates in patients with delayed gastric
transit risk factors.
Patients and methods
Conducted as a single-center, prospective, open-label, non-inferiority trial, the
study involved 132 patients identified as at risk for delayed gastric transit. Participants
were divided into three groups: peppermint oil solution group (n = 57), real-time
monitoring and intravenous prokinetics group (n = 75), and control group without risk
factors (n = 193). Primary outcomes included SBCE completion rates, gastric transit
time (GTT), small bowel transit time (SBTT), diagnostic yield, and bowel preparation
quality.
Results
Completion rates were high and comparable among groups, with 94.7% in the peppermint
group, 90.7% in the real-time monitoring group, and 95.3% in the control group. The
peppermint group exhibited a significantly shorter mean GTT of 42.3 minutes compared
with 57.0 minutes in the real-time monitoring group (P = 0.0423). However, SBTT was longer in the peppermint group at 246 minutes versus
193 minutes in the real-time monitoring group (P = 0.0081), although similar to the control group at 228.3 minutes (P = 0.2612). Diagnostic yield and bowel preparation quality were consistent across
all groups.
Conclusions
Oral peppermint oil solution is a safe and effective alternative to traditional prokinetics,
enhancing SBCE completion rates while reducing time and resource use in the endoscopy
unit.
Keywords
Endoscopy Small Bowel - Capsule endoscopy - Endoscopy Upper GI Tract - Diagnosis and
imaging (inc chromoendoscopy, NBI, iSCAN, FICE, CLE)
Bibliographical Record
Fintan John O'Hara, Conor Costigan, Deirdre Mc Namara. Orally peppermint oil in small
bowel capsule endoscopy: Novel approach to improve completion rates in patients at
risk of delayed gastric transit. Endosc Int Open 2025; 13: a24656918.
DOI: 10.1055/a-2465-6918